Relatively new bio Pharma fund, led by a dynamic and well respected team, currently having invested in 6 companies to date, taking lead position in all plus a board seat, having 15 medicines in human trials, projecting 3 IPOs this year of which one formally announced a week ago, seeking investors at a minimum of $1 million for individuals and $5 million for institutional investors.
Jan 31, 2025